Abortion rights supporters hail win for evidence-backed medicine as Evita Solutions’ generic version of mifepristone given approval
In a move that has left anti-abortion advocates reeling, the US Food and Drug Administration (FDA) quietly approved a request to manufacture a new abortion pill earlier this week.
Thanks to the approval, a company called Evita Solutions will be able to manufacture its generic version of mifepristone, one of two drugs typically used in most US medication abortions. A generic version of mifepristone, which was first approved as a brand-name drug in 2000, is already available on the market.
